Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Review Article January 18 2025
Peripheral T-Cell Lymphoma-NOS in Children and Adolescents: a Review from the Children's Oncology Group NHL Committee
Research Article January 18 2025
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels
Research Article January 18 2025
Characterization of the Phenotypic Consequences of the Duffy-Null Genotype
Letter January 18 2025
PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB
Research Article January 18 2025
PRMT5 Inhibition Reduces Hyperinflammation in a Murine Model of Secondary Hemophagocytic Lymphohistiocytosis (HLH)
Research Article January 18 2025
Final Analysis of the Phase 1b Chemotherapy And Venetoclax in Elderly Acute Myeloid Leukaemia Trial (CAVEAT)
Research Article January 18 2025
Definitions and use of tumour bulk in phase 3 lymphoma trials: a comprehensive literature review
Research Article January 16 2025
Stroke Prevention in Hispanic Children with Sickle Cell Anemia: the SACRED trial
Research Article January 16 2025
Relationship between additional mutations at diagnosis and treatment response in patients with essential thrombocythemia
Research Article January 16 2025
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL
Research Article January 16 2025
Phase 1 Study of Quercetin, a Natural Antioxidant in Children and Young Adults with Fanconi Anemia (FA)
Letter January 16 2025
Differential effects of C5 inhibition, C3 inhibition and alternative pathway inhibition on bacterial killing in vitro
Research Article January 16 2025
Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients
Review Article January 15 2025
Current developments in T-cell receptor therapy for Acute Myeloid Leukaemia
Research Article January 15 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP
Letter January 15 2025
Thalassemia carriers exhibit reduced expression of CD234 on erythrocytes and levels of malaria-associated chemokines
Research Article January 15 2025
α-Actinin-1 deficiency in megakaryocytes causes low platelet count, platelet dysfunction, and mitochondrial impairment
Letter January 15 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma
Research Article January 14 2025
Socioeconomic, Race-Ethnicity, Household, and Infrastructure Disparities of Hematologic Cancer Outcomes in the US
Research Article January 14 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
Research Article January 14 2025
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultra-high-risk pediatric T-ALL patients
Research Article January 14 2025
The role of genetic sequencing in the diagnostic work-up for chronic immune thrombocytopenia
Letter January 14 2025
Platelet potential to switch to procoagulant phenotype compensates bleeding tendency in patients with hemophilia A
Research Article January 14 2025
Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial
Research Article January 9 2025
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke
Reply January 9 2025
International Consensus in Aiming to Define "Refractory ITP"
Letter January 9 2025
Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study
Letter January 8 2025
The A-HIPI Prediction Model in Advanced Stage Hodgkin Lymphoma: Identification of Risk Groups and Creation of an Online Tool
Review Article January 7 2025
Imetelstat: Drugging Telomerase in Transfusion-Dependent Low and Intermediate-1 Risk MDS
Research Article January 7 2025
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients. A multicenter study by EBMT IEWP
Letter January 7 2025
Combination therapies of porcupine inhibition with ruxolitinib, ibrutinib or belumosudil in murine sclerodermatous GvHD
Research Article January 7 2025
Pre-treatment Pulmonary Function Testing Has Limited Utility In B-cell Lymphoma Treated with CD19 CAR T-cells
Research Article January 7 2025
Patient-Reported Improvements in Patients with PNH Treated with Iptacopan from Two Phase 3 Studies
Research Article January 7 2025
Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS
Research Article January 7 2025
Dual ASXL1 and CSF3R mutations drive myeloid biased stem cell expansion and enhance neutrophil differentiation
Research Article January 7 2025
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Letter January 2 2025
Characteristics of Infections after BCMA-directed CAR-T cells therapy for Multiple Myeloma - a real-world analysis
Review Article December 30 2024
Advancing Drug Development in Myelodysplastic Syndromes
Letter December 30 2024
Long Term Follow up of Total Therapy IV: A Phase III Clinical Trial for Standard Risk Multiple Myeloma
Letter December 30 2024
Outcomes of Older Adults and Frail Patients Receiving Idecabtagene Vicleucel: A CIBMTR Study
Research Article December 27 2024
Real-World Treatment Patterns and Healthcare Resource Use for Patients with Myelofibrosis: Results from the METER Study
Research Article December 27 2024
BCMA-directed CAR T-cell Therapy in patients with multiple myeloma and CNS involvement
Letter December 27 2024
Anti-FcRL5 CAR-T exhibit anti-MM activity against EMM after progression of anti-BCMA and anti-GPRC5D CAR-T:a case report
Review Article December 23 2024
CAR-T cell therapies for T cell malignancies: does cellular immunotherapy represent the best chance of cure?
Research Article December 23 2024
Impact of Clinical Factors on Accuracy of Ovarian Cancer Detection via Platelet RNA Profiling
Research Article December 23 2024
Genome-wide CRISPR screen identifies AraC-Dauno-Eto (ADE) response modulators that predicts outcome in pediatric AML
Letter December 23 2024
Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia
Letter December 20 2024
Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia
Research Article December 20 2024
Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis
Letter December 20 2024
G3BP1::CSF1R: a new and actionable gene fusion in acute megakaryoblastic leukemia
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals